Priya Kumar

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

Ezra E.W. Cohen, Theodore Karrison, Masha Kocherginsky et al. · Journal of Clinical Oncology · 2014 · 569 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

Keith C. Bible, Vera J. Suman, Michael E. Menefee et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 176 citations · Full text

Medicine, Oncology, Pharmacology +15

DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Ezra E.W. Cohen, Theodore Karrison, Masha Kocherginsky et al. · Journal of Clinical Oncology · 2012 · 136 citations

Medicine, Radiation Oncology, Chemotherapy +5

Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes

Neha J. Pagidipati, Adam J. Nelson, Lisa A. Kaltenbach et al. · JAMA · 2023 · 95 citations · Full text

Medicine, Cardiology, Chronic Disease Prevention +17